Vimarsana
Biggest News Aggregation in the World

Poster Viewing Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Viewing Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Viewing Session Today - Breaking & Trending Today

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -October 11, 2023 at 10:03 am EDT - Vimarsana News

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -October 11, 2023 at 10:03 am EDT

MATERIAL CHANGE REPORT - Name and Address of Company Cardiol Therapeutics Inc. 2265 Upper Middle Road East, Suite 602 Oakville, Ontario,...

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction - Vimarsana News

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart...

Cardiol Therapeutics Inc. Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in Model of Heart Failure with Preserved Ejection Fraction - Vimarsana News

Cardiol Therapeutics Inc. Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in Model of Heart Failure with Preserved Ejection Fraction

Cardiol Therapeutics Inc. announced positive study results from one of its international collaborating research centers demonstrating that subcutaneously administered cannabidiol, the active...

Cytokinetics Announces Upcoming Presentations at the 2023 - Vimarsana News

Cytokinetics Announces Upcoming Presentations at the 2023

Baseline Characteristics from SEQUOIA-HCM to be Presented at HCMS Scientific Sessions on October 6, 2023...

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference - Vimarsana News

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference

Kira Pharmaceuticals to Present New Preclinical Data on Lead Asset KP104 at the 2022 European Meeting on Complement in Human Disease Conference - read this article along with other careers information, tips and advice on BioSpace